| Name | Title | Contact Details |
|---|---|---|
Christopher Chipman |
Chief Financial Officer | Profile |
Vinay Shah |
Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer | Profile |
International Stem Cell Corporation is a Oceanside, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Tetragenex Pharmaceuticals is a Syosset, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
More than an OEM company, IntriCon is invested in creating a hearing healthcare system to offer individuals hearing help at a cost they can afford.
Cychem, Inc. is a Westlake Village, CA-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Oncternal Therapeutics is a clinical-stage oncology company developing a diverse pipeline of treatments for cancers with critical unmet medical need. Oncternal focuses drug development on promising yet untapped biological pathways implicated in cancer progression. The pipeline includes cirmtuzumab, a monoclonal antibody in Phase 1/2 development that inhibits the ROR1 receptor in various hematologic cancers; TK-216, a small-molecule in Phase 1 development that inhibits ETS-family oncoproteins, as a treatment for Ewing sarcoma, a rare pediatric cancer; and a CAR-T therapy that targets ROR1 currently in preclinical development as a potential treatment for solid tumors and hematologic cancers. Based in San Diego, Oncternal is committed to advancing its pipeline rapidly and efficiently to bring patients a new wave of first-in-class cancer treatments.